These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12031278)

  • 1. Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease.
    Alberch J; Pérez-Navarro E; Canals JM
    Brain Res Bull; 2002 Apr; 57(6):817-22. PubMed ID: 12031278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease.
    Pérez-Navarro E; Akerud P; Marco S; Canals JM; Tolosa E; Arenas E; Alberch J
    Neuroscience; 2000; 98(1):89-96. PubMed ID: 10858615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo.
    Pérez-Navarro E; Arenas E; Marco S; Alberch J
    Eur J Neurosci; 1999 Jan; 11(1):241-9. PubMed ID: 9987028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease.
    Emerich DF; Winn SR; Hantraye PM; Peschanski M; Chen EY; Chu Y; McDermott P; Baetge EE; Kordower JH
    Nature; 1997 Mar; 386(6623):395-9. PubMed ID: 9121555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
    Araujo DM; Hilt DC
    Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members.
    Gratacòs E; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
    J Neurochem; 2001 Sep; 78(6):1287-96. PubMed ID: 11579137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease.
    Pérez-Navarro E; Canudas AM; Akerund P; Alberch J; Arenas E
    J Neurochem; 2000 Nov; 75(5):2190-9. PubMed ID: 11183872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotrophic factors in Huntington's disease.
    Alberch J; Pérez-Navarro E; Canals JM
    Prog Brain Res; 2004; 146():195-229. PubMed ID: 14699966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatopallidal neurons are selectively protected by neurturin in an excitotoxic model of Huntington's disease.
    Marco S; Pérez-Navarro E; Tolosa E; Arenas E; Alberch J
    J Neurobiol; 2002 Mar; 50(4):323-32. PubMed ID: 11891666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum.
    Marco S; Canudas AM; Canals JM; Gavaldà N; Pérez-Navarro E; Alberch J
    Exp Neurol; 2002 Apr; 174(2):243-52. PubMed ID: 11922665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo.
    Pérez-Navarro E; Alberch J; Neveu I; Arenas E
    Neuroscience; 1999; 91(4):1257-64. PubMed ID: 10391433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
    Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
    McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage.
    Pérez-Navarro E; Arenas E; Reiriz J; Calvo N; Alberch J
    Neuroscience; 1996 Nov; 75(2):345-52. PubMed ID: 8931001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease.
    Canals JM; Pineda JR; Torres-Peraza JF; Bosch M; Martín-Ibañez R; Muñoz MT; Mengod G; Ernfors P; Alberch J
    J Neurosci; 2004 Sep; 24(35):7727-39. PubMed ID: 15342740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial cell line-derived neurotrophic factor attenuates the locomotor hypofunction and striatonigral neurochemical deficits induced by chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid.
    Araujo DM; Hilt DC
    Neuroscience; 1998 Jan; 82(1):117-27. PubMed ID: 9483508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease.
    Glass M; Dragunow M; Faull RL
    Neuroscience; 2000; 97(3):505-19. PubMed ID: 10828533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Modification Through Trophic Factor Delivery.
    Savolainen M; Emerich D; Kordower JH
    Methods Mol Biol; 2018; 1780():525-547. PubMed ID: 29856034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.